Australian Clinical Labs to withdraw takeover offer for Healius
14/12/2023 22:32
Dec 15 (Reuters) - Australian Clinical Labs ACL.AX said on Friday it intends to withdraw its takeover offer for Healius HLS.AX . (Reporting by Echha Jain in Bengaluru; Editing by Shinjini Ganguli) ((Echha.Jain@thomsonreuters.com;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million